Codagenix Inc. is a clinical stage biotechnology company with vaccine products against influenza, respiratory syncytial virus, dengue virus, and others currently under development.

Biotechnology

Codagenix

Codagenix's headquarters in Farmingdale, NY, United States

Steffen Mueller

Gerard Cunningham

Tyler Cook

Jeffrey Fu

Keri Wyllie

Kimber Poffenberger

Bruce E. Taillon

Chen Yang

Steven Winick

Larry Norton

Stanley Plotkin

Gavin Corcoran

George E. Peoples

Steven Burakoff

Eckard Wimmer

Glenn Rockman

Wayne Koff

Paul Grint

Jill Howe

Lori Rudolph-Owen

The Executive Team at Codagenix Inc. oversees the strategic direction and overall operations of the company, ensuring alignment with long-term goals. They are responsible for guiding the development of vaccine products, financial planning, business growth, and managing key stakeholder relationships.

Executive Team

The Scientific Advisory Team at Codagenix Inc. provides expert guidance on the development and optimization of vaccine candidates. Comprised of seasoned Scientific Advisors, the team evaluates research data, advises on strategic scientific directions, and ensures the company's vaccine products meet the highest standards of efficacy and safety.

Scientific Advisory Team

The Research and Development team at Codagenix Inc. spearheads the creation and refinement of next-generation vaccines, focusing on influenza, respiratory syncytial virus, dengue virus, and other infectious diseases. Comprising experts in virus research, synthetic vaccine development, and preclinical operations, the team leads projects from conceptualization through preclinical stages to ensure innovative and effective vaccine solutions.

Research and Development

The Clinical Project Management team at Codagenix oversees the planning, implementation, and coordination of clinical trials for the company's vaccine products. They ensure the studies adhere to regulatory standards, manage timelines and budgets, and facilitate communication between internal departments and external stakeholders to advance the development of vaccines against diseases like influenza, respiratory syncytial virus, and dengue virus.

Clinical Project Management

The Leadership Team at Codagenix is responsible for setting the strategic vision and direction for the company, overseeing research and development initiatives, and fostering partnerships to advance the development of innovative vaccine products. With expertise in business and scientific fields, they work collaboratively to ensure the successful progression of clinical trials and drive the company's mission to deliver effective vaccines against infectious diseases.

Codagenix

Org chart

Board & advisors

Teams

Executive Team

Scientific Advisory Team

Research and Development

Clinical Project Management

Leadership Team

Offices

Codagenix

Org chart

Board & advisors

Teams

Executive Team

Scientific Advisory Team

Research and Development

Clinical Project Management

Leadership Team

Offices

Related companies